Related Experiment Video
Updated: Sep 20, 2025

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
Published on: August 19, 2021
Bacteriostatic effects of phage F23s1 and its endolysin on Vibrio parahaemolyticus
Hai Xia1, Houji Yang1, Na Yan1
1Department of Food Quality and Safety, School of Food Science and Engineering, Wuhan Polytechnic University, Wuhan, China.
Abstract:
Vibrio parahaemolyticus is a common foodborne pathogenic bacterium and drug-resistant strains are now widespread. Phages led by drug-resistant V. parahaemolyticus strains are promising means to decrease the pressure on public health. We isolated a V. parahaemolyticus-specific bacteriophage F23s1 that was active at wide ranges of temperature (30-60°C) and pH (4-10). Phage F23s1 exhibited a specific host range; in that, only 13 of the 23 V. parahaemolyticus strains were lysed. F23s1 effectively inhibited the growth of V. parahaemolyticus strain F23 in shrimp at 25°C within 12 h at a multiplicity of infection of 1000. We sequenced the genome of phage F23s1 which comprised a 76,648-bp DNA with 105 open reading frames (ORFs) and identified an endolysin gene ORF52 that was then cloned and successfully expressed in Escherichia coli. The recombinant ORF52 protein significantly decreased OD600 nm of V. parahaemolyticus F23 from 0.978 to 0.249 when used at 20 µmol/L within 60 min. The endolysin also showed lytic activity against a panel of 23 drug-resistant V. parahaemolyticus and 12 Salmonella strains with a higher lytic ability for V. parahaemolyticus. The phage F23s1 and its endolysin will be useful for preventing and controlling V. parahaemolyticus in food safety.
Insights
A novel bacteriophage, F23s1, and its endolysin show promise for controlling drug-resistant Vibrio parahaemolyticus. This phage therapy approach offers a potential solution for food safety and public health concerns.
Area of Science:
- Microbiology
- Bacteriology
- Food Safety
Background:
- Vibrio parahaemolyticus is a significant foodborne pathogen.
- Drug-resistant strains are increasingly prevalent, posing public health challenges.
- Bacteriophage therapy presents a potential alternative to antibiotics.
Purpose of the Study:
- To isolate and characterize a bacteriophage targeting Vibrio parahaemolyticus.
- To evaluate the efficacy of the bacteriophage and its derived endolysin in controlling V. parahaemolyticus.
- To assess the potential of phage F23s1 and its endolysin in food safety applications.
Main Methods:
- Isolation and characterization of Vibrio parahaemolyticus-specific bacteriophage F23s1.
- Genome sequencing of phage F23s1 and identification of endolysin gene ORF52.
- Cloning and expression of the endolysin gene in Escherichia coli.
- In vitro and in vivo efficacy testing against V. parahaemolyticus.
Main Results:
- Phage F23s1 demonstrated activity across a wide pH and temperature range.
- F23s1 effectively inhibited V. parahaemolyticus growth in shrimp.
- The recombinant endolysin ORF52 exhibited significant lytic activity against drug-resistant V. parahaemolyticus and Salmonella strains.
Conclusions:
- Phage F23s1 and its endolysin are effective against Vibrio parahaemolyticus.
- These agents show potential for preventing and controlling V. parahaemolyticus contamination in food.
- This research contributes to the development of novel strategies for combating foodborne pathogens.
More Related Videos
Related Concept Videos
Lytic Cycle of Bacteriophages
Lysogenic Cycle of Bacteriophages
Viral Replication: Lysogenic Cycle
Viral Replication: Lytic Cycle
DNA Bacteriophages

